- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Budesonide – March 2019
Budesonide: Capsule (modified release) 3 mg; Budenofalk®
Last updated
5 July 2019
